Quantcast

Latest Sirtuin Stories

2009-01-25 16:00:00

SAN DIMAS, Calif., Jan. 25 /PRNewswire/ -- A red wine resveratrol (rez-vair-ah-trawl) pill is edging closer to being confirmed as an anti-aging pill as researchers at LifeGen Technologies in Madison, Wisconsin, who were recently interviewed on CBS-TV's 60 MINUTES, reported this past September that Longevinex(R), a patent-applied-for nutriceutical matrix, activates 9-fold more longevity genes than plain resveratrol at a far lower dose than previously reported. (Photo:...

2008-12-27 12:06:00

SAN DIMAS, Calif., Dec. 27 /PRNewswire/ -- According to the latest science, resveratrol pill users are best advised to consume modest doses of resveratrol plus an array of antioxidant molecules as typically provided in 3 to 5 glasses of aged, red wine, rather than resveratrol alone. (Photo: http://www.newscom.com/cgi-bin/prnh/20080603/LATU039 ) The most recent study shows mega-dose resveratrol alone fails to prolong the life of laboratory mice. In fact, mega-doses shortened...

2008-11-28 07:54:01

Harvard researchers report finding a new clue into the reason for aging in a minor ingredient of red wine and its role in activating a protein. Scientists said they made their finding while trying to understand how the agent resveratrol improves the health and lifespan of laboratory mice, The New York Times reported. In their finding, published online in the journal Cell, a group led by David Sinclair of the Harvard Medical School said it was believed that the integrity of chromosomes is...

2008-11-11 03:00:09

RevGenetics (http://www.revgenetics.com/), at the forefront of developing uncommonly effective products using common herbal ingredients, unveils Sirtuin Skin, a resveratrol powered skin care cream. Sirtuin Skin is a resveratrol cream with proven peptides that revitalizes and moisturizes, making skin look and feel younger, longer. Derived from varying sources, including certain red grape skins, resveratrol is considered most beneficial for a broad range of age related conditions because of its...

2008-10-29 09:00:05

Research and Markets (http://www.researchandmarkets.com/research/736e52/molecular_biology) has announced the addition of the "Molecular Biology of Aging" report to their offering. Research into the causes of aging, and strategies to delay that process, have gained much ground and attention in recent years. This volume covers the major threads in the molecular genetics of aging, including genes that regulate aging, causes of aging, evolutionary theories of aging, and the relationship...

2008-10-17 09:00:27

Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, today announced that it will provide an update on the Company's clinical and preclinical progress at the 2008 Boston Biotech R&D Conference on Wednesday, October 22, 2008 at Harvard Medical School. Christoph Westphal, M.D., Ph.D., Chief Executive Officer of Sirtris, a GSK company, will provide an update on the Company's lead new chemical entity (NCE)...

2008-10-01 09:00:12

CAMBRIDGE, Mass., Oct. 1 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, today announced the publication of a paper authored by Gil Blander, Ph.D. et al, titled "SIRT1 Promotes Differentiation of Normal Human Keratinocytes" in the Journal of Investigative Dermatology. This research, led by Genstruct scientists and supported in part through an Estee...

2008-10-01 09:00:09

Sirtris, a GSK company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it published a new review article on the growing body of sirtuin research and its potential to treat diseases of aging such as Type 2 Diabetes, mitochondrial disorders, inflammation, cancer, and heart disease. Entitled "SIRTUINS - Novel Therapeutic Targets to Treat Age-Associated Diseases," the review appears in today's issue of the journal...

2008-09-17 12:00:35

Sirtris, a GlaxoSmithKline company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 diabetes, has completed an agreement with Harvard University to exclusively license two patent applications covering SIRT3-based methods of treatments and assays. Sirtuins are a family of enzymes which regulate the aging process and have been the subject of extensive research. While SIRT1 - the founding member of this class of enzymes - is currently the...

2008-09-16 09:00:15

Sirtris, a GSK Company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that it has completed an agreement with Harvard University to exclusively license two patent applications covering SIRT3-based methods of treatments and assays. Sirtuins are a family of enzymes which regulate the aging process and have been the subject of extensive research. While SIRT1 -- the founding member of this class of enzymes -- is...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.